Atlas Trials

Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients

Clinical trial NCT03030508 · UNKNOWN

Trial details

NCT number
NCT03030508
Sponsor
Shanghai Changzheng Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Colorectal CancerCapecitabine
Start date
2016-01-01
Primary completion
2019-01-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.